Wave Life Sciences is trading at $3.76, a -5.05% change, with no confirmed company-specific announcement explaining the intraday decline.

  • The price was as of 3:37 p.m. EST on September 25, 2026.
  • JPMorgan’s September 23 move to Neutral from Overweight was reported alongside earlier weakness, but available coverage does not establish it as the cause of this session’s decline.
  • The broader market was higher, so the move does not appear to track the supplied index trend. No reliable volume figure was available.